David Abrams – Abrams Capital
Opened 1 new position, none closed. Largest change: opened GFL (2.1 pts of portfolio). Reported value $4.81B, down 12.3% from Q2 2026. Top 10 holdings are 100% of reported value.
Largest increases vs Q2 2026
- GFL New 2.1 pts
Largest decreases vs Q2 2026
None this quarter.
Most similar portfolios
- David Rolfe 2 shared stocks · 14.7% of this portfolio
- Chase Coleman 3 shared stocks · 18.5% of this portfolio
- Samantha McLemore 2 shared stocks · 14.7% of this portfolio
- Li Lu 1 shared stock · 9.8% of this portfolio
- Nick Train 1 shared stock · 9.8% of this portfolio
Holdings
| Stock | Company | % of portfolio | Change vs Q2 2026 | Shares | Reported price* | Reported value |
|---|---|---|---|---|---|---|
| LOAR | Loar Holdings Inc | 41.02 | 32,050,240 | $61.52 | $1.97B | |
| LAD | Lithia Motors Inc | 15.12 | 2,490,534 | $291.83 | $726.8M | |
| GOOGL | Alphabet Inc-Cl A | 9.81 | 1,370,495 | $344.08 | $471.6M | |
| ABG | Asbury Automotive Group | 7.73 | 2,155,492 | $172.30 | $371.4M | |
| SGI | Somnigroup International Inc | 7.49 | 5,798,776 | $62.11 | $360.2M | |
| META | Meta Platforms Inc-Class A | 4.91 | 325,155 | $725.18 | $235.8M | |
| WTW | Willis Towers Watson PLC | 4.32 | 720,779 | $288.23 | $207.8M | |
| CPNG | Coupang Inc | 3.76 | 13,017,964 | $13.87 | $180.6M | |
| UHAL.B | U-Haul Holding Co-Non Voting | 3.58 | 3,251,469 | $52.85 | $171.8M | |
| GFL | Gfl Environmental Inc-Sub Vt | 2.07 | New | 2,375,000 | $41.83 | $99.3M |
| NUVB | Nuvation Bio Inc | 0.15 | 1,270,504 | $5.60 | $7.1M | |
| UHAL | U-Haul Holding Co | 0.05 | 36,401 | $60.17 | $2.2M |
* Reported price = reported value ÷ shares as of 30 Sep 2026, not a current price. Percentages are of 13F-reported long US equity value only.
Activity: Q3 2026 vs Q2 2026
| Stock | Company | Change | Effect on portfolio (pts) |
|---|---|---|---|
| GFL | Gfl Environmental Inc-Sub Vt | New | 2.07 |
Effect on portfolio = change in shares × reported price, as a share of this quarter's reported value.
Added: opened or increased positions
Q3 2026 vs Q2 2026 · filed 13 Nov 2026
| Stock | Company | Change | Effect (pts) | Shares | Reported value |
|---|---|---|---|---|---|
| GFL | Gfl Environmental Inc-Sub Vt | New | 2.07 | 2,375,000 | $99.3M |
Q2 2026 vs Q1 2026 · filed 13 Aug 2026
None this quarter.
Q1 2026 vs Q4 2025 · filed 14 May 2026
None this quarter.
Q4 2025 vs Q3 2025 · filed 13 Feb 2026
None this quarter.
Reduced: reduced or closed positions
Q3 2026 vs Q2 2026 · filed 13 Nov 2026
None this quarter.
Q2 2026 vs Q1 2026 · filed 13 Aug 2026
| Stock | Company | Change | Effect (pts) | Shares | Reported value |
|---|---|---|---|---|---|
| GOOGL | Alphabet Inc-Cl A | Reduced 26.5% | 3.23 | 1,370,495 | $489.8M |
Q1 2026 vs Q4 2025 · filed 14 May 2026
| Stock | Company | Change | Effect (pts) | Shares | Reported value |
|---|---|---|---|---|---|
| ET | Energy Transfer LP | Closed | 1.78 | 0 | – |
| GOOGL | Alphabet Inc-Cl A | Reduced 2.7% | 0.32 | 1,865,768 | $536.5M |
| NUVB | Nuvation Bio Inc | Reduced 66.7% | 0.24 | 1,270,504 | $5.5M |
| SGI | Somnigroup International Inc | Reduced 0.1% | 0.01 | 5,798,776 | $428.6M |
Q4 2025 vs Q3 2025 · filed 13 Feb 2026
| Stock | Company | Change | Effect (pts) | Shares | Reported value |
|---|---|---|---|---|---|
| GOOGL | Alphabet Inc-Cl A | Reduced 9.8% | 1.14 | 1,916,630 | $599.9M |
| META | Meta Platforms Inc-Class A | Reduced 17.6% | 0.81 | 325,155 | $214.6M |
| CRCL | Circle Internet Group Inc | Closed | 0.59 | 0 | – |
| SGI | Somnigroup International Inc | Reduced 0.7% | 0.06 | 5,804,136 | $518.2M |
| ET | Energy Transfer LP | Reduced 1.5% | 0.03 | 6,115,417 | $100.8M |
History
$6.23B peakQ3 2026: $4.81B
20132026
22 peakQ3 2026: 12
20132026
| Period | Filed | Reported value | Stocks | New | Closed | Largest positions |
|---|---|---|---|---|---|---|
| Q3 2026 | 13 Nov 2026 | $4.81B | 12 | 1 | 0 | LOAR, LAD, GOOGL |
| Q2 2026 | 13 Aug 2026 | $5.48B | 11 | 0 | 0 | LOAR, LAD, GOOGL |
| Q1 2026 | 14 May 2026 | $4.64B | 11 | 0 | 1 | LOAR, LAD, GOOGL |
| Q4 2025 | 13 Feb 2026 | $5.67B | 12 | 0 | 1 | LOAR, LAD, GOOGL |
| Q3 2025 | 7 Nov 2025 | $6.17B | 13 | 0 | 0 | LOAR, LAD, ABG |
| Q2 2025 | 8 Aug 2025 | $6.11B | 13 | 1 | 1 | LOAR, LAD, ABG |
| Q1 2025 | 9 May 2025 | $5.64B | 13 | 0 | 0 | LOAR, LAD, ABG |
| Q4 2024 | 7 Feb 2025 | $6.22B | 13 | 0 | 1 | LOAR, LAD, ABG |
| Q3 2024 | 8 Nov 2024 | $6.23B | 14 | 0 | 0 | LOAR, LAD, ABG |
| Q2 2024 | 9 Aug 2024 | $5.11B | 14 | 1 | 0 | LOAR, LAD, ABG |
| Q1 2024 | 14 May 2024 | $3.20B | 13 | 0 | 2 | LAD, ABG, GOOGL |
| Q4 2023 | 9 Feb 2024 | $3.22B | 15 | 0 | 0 | LAD, ABG, GOOGL |
| Q3 2023 | 13 Nov 2023 | $3.03B | 15 | 0 | 2 | LAD, ABG, GOOGL |
| Q2 2023 | 14 Aug 2023 | $3.48B | 17 | 1 | 0 | LAD, ABG, META |
| Q1 2023 | 12 May 2023 | $3.16B | 16 | 0 | 0 | LAD, META, ABG |
| Q4 2022 | 10 Feb 2023 | $2.80B | 16 | 1 | 3 | LAD, ABG, META |
| Q3 2022 | 10 Nov 2022 | $3.47B | 18 | 0 | 0 | LAD, Change Healthcare Inc, ABG |
| Q2 2022 | 12 Aug 2022 | $3.72B | 18 | 0 | 0 | LAD, Change Healthcare Inc, ABG |
| Q1 2022 | 13 May 2022 | $4.28B | 18 | 0 | 0 | LAD, GOOGL, Change Healthcare Inc |
| Q4 2021 | 11 Feb 2022 | $4.56B | 18 | 1 | 1 | LAD, GOOGL, META |
| Q3 2021 | 12 Nov 2021 | $4.59B | 18 | 3 | 1 | LAD, ABG, META |
| Q2 2021 | 13 Aug 2021 | $4.50B | 16 | 1 | 1 | LAD, META, ABG |
| Q1 2021 | 14 May 2021 | $4.44B | 16 | 3 | 4 | LAD, ABG, META |
| Q4 2020 | 12 Feb 2021 | $3.55B | 17 | 0 | 2 | LAD, TDG, META |
| Q3 2020 | 13 Nov 2020 | $3.16B | 19 | 0 | 1 | LAD, META, TDG |
| Q2 2020 | 13 Aug 2020 | $3.09B | 20 | 0 | 2 | LAD, Teva Pharmaceutical-Sp Adr, META |
| Q1 2020 | 14 May 2020 | $2.54B | 22 | 2 | 1 | PCG, Allergan PLC, Teva Pharmaceutical-Sp Adr |
| Q4 2019 | 14 Feb 2020 | $3.22B | 21 | 3 | 2 | LAD, PCG, BEN |
| Q3 2019 | 14 Nov 2019 | $3.57B | 20 | 2 | 1 | Celgene Corp, LAD, BEN |
| Q2 2019 | 9 Aug 2019 | $3.68B | 19 | 2 | 2 | Celgene Corp, PCG, BEN |
| Q1 2019 | 10 May 2019 | $3.56B | 19 | 3 | 3 | Celgene Corp, PCG, BEN |
| Q4 2018 | 14 Feb 2019 | $2.42B | 19 | 2 | 5 | BEN, ORLY, Teva Pharmaceutical-Sp Adr |
| Q3 2018 | 9 Nov 2018 | $3.78B | 22 | 3 | 3 | Teva Pharmaceutical-Sp Adr, Shire PLC, WU |
| Q2 2018 | 13 Aug 2018 | $3.59B | 22 | 3 | 1 | Teva Pharmaceutical-Sp Adr, WU, Aetna Inc New |
| Q1 2018 | 11 May 2018 | $3.19B | 20 | 2 | 2 | WU, Teva Pharmaceutical-Sp Adr, Time Warner Inc |
| Q4 2017 | 13 Feb 2018 | $2.97B | 20 | 2 | 0 | WU, Teva Pharmaceutical-Sp Adr, BEN |
| Q3 2017 | 14 Nov 2017 | $2.56B | 18 | 4 | 5 | WU, Teva Pharmaceutical-Sp Adr, BEN |
| Q2 2017 | 11 Aug 2017 | $2.52B | 19 | 3 | 1 | WU, BEN, Time Warner Inc |
| Q1 2017 | 12 May 2017 | $2.61B | 17 | 3 | 5 | WU, BEN, MSFT |
| Q4 2016 | 10 Feb 2017 | $2.72B | 19 | 5 | 2 | WU, BEN, MSFT |
| Q3 2016 | 14 Nov 2016 | $2.01B | 16 | 0 | 1 | WU, MSFT, BEN |
| Q2 2016 | 12 Aug 2016 | $1.91B | 17 | 1 | 2 | WU, BEN, MSFT |
| Q1 2016 | 13 May 2016 | $2.12B | 18 | 4 | 2 | WU, BEN, MSFT |
| Q4 2015 | 12 Feb 2016 | $1.83B | 16 | 2 | 0 | WU, MSFT, BEN |
| Q3 2015 | 13 Nov 2015 | $1.40B | 14 | 4 | 2 | WU, MSFT, WFC |
| Q2 2015 | 13 Aug 2015 | $1.47B | 12 | 1 | 1 | WU, MSFT, Directv |
| Q1 2015 | 14 May 2015 | $1.34B | 12 | 1 | 4 | WU, MSFT, WFC |
| Q4 2014 | 13 Feb 2015 | $1.93B | 15 | 2 | 0 | WU, Covidien PLC, AIG |
| Q3 2014 | 13 Nov 2014 | $1.69B | 13 | 3 | 5 | WU, AIG, MSFT |
| Q2 2014 | 13 Aug 2014 | $1.42B | 15 | 4 | 2 | WU, AIG, WFC |
| Q1 2014 | 14 May 2014 | $1.26B | 13 | 2 | 2 | WU, AIG, SLM |
| Q4 2013 | 13 Feb 2014 | $1.27B | 13 | 3 | 1 | WU, SLM, AIG |
| Q3 2013 | 13 Nov 2013 | $1.28B | 11 | 0 | 4 | WU, SLM, AIG |
| Q2 2013 | 13 Aug 2013 | $1.73B | 15 | SLM, WU, AIG |